Detalhe da pesquisa
1.
Metabonomics in Gastroenterology and Hepatology.
Int J Mol Sci
; 20(15)2019 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31349596
2.
Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease.
BMC Med
; 15(1): 184, 2017 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29032767
3.
Integrative transcriptomic and metabonomic molecular profiling of colonic mucosal biopsies indicates a unique molecular phenotype for ulcerative colitis.
J Proteome Res
; 14(1): 479-90, 2015 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25283053
4.
Biological treatment of Crohn's disease.
Dig Dis
; 30 Suppl 3: 121-33, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23295703
5.
Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets.
Int J Biol Sci
; 18(5): 1813-1828, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35342362
6.
Early Intestinal Ultrasound Predicts Intravenous Corticosteroid Response in Hospitalised Patients With Severe Ulcerative Colitis.
J Crohns Colitis
; 16(11): 1725-1734, 2022 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35695823
7.
[Practical guide to the use of thiopurinesin patients with inflammatory bowel diseases].
Ugeskr Laeger
; 184(11)2022 03 14.
Artigo
em Da
| MEDLINE | ID: mdl-35315759
8.
Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report.
BMJ Open Gastroenterol
; 9(1)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581371
9.
Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitis.
Aliment Pharmacol Ther
; 56(9): 1370-1382, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36123319
10.
Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial.
EClinicalMedicine
; 45: 101332, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274092
11.
COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis.
J Immunother Cancer
; 10(9)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096534
12.
Non-infectious HIV-associated colitis as a differential diagnosis to ulcerative colitis.
Scand J Gastroenterol
; 51(8): 1017-8, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27152639
13.
Acute Experimental Barrier Injury Triggers Ulcerative Colitis-Specific Innate Hyperresponsiveness and Ulcerative Colitis-Type Microbiome Changes in Humans.
Cell Mol Gastroenterol Hepatol
; 12(4): 1281-1296, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34118489
14.
Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies.
Nat Commun
; 9(1): 1661, 2018 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29695774
15.
Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis.
Inflamm Bowel Dis
; 21(5): 1077-88, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25803506
16.
Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals.
Metabolomics
; 11: 122-133, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25598765
17.
[Ulcerative colitis].
Ugeskr Laeger
; 176(10A)2014 Mar 03.
Artigo
em Da
| MEDLINE | ID: mdl-25350705
18.
Integration of transcriptomics and metabonomics: improving diagnostics, biomarker identification and phenotyping in ulcerative colitis.
Metabolomics
; 10(2): 280-290, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25221466
19.
Identification of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2.
DNA Res
; 21(6): 569-83, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24990076
20.
Recent advances using immunomodulators for inflammatory bowel disease.
J Clin Pharmacol
; 53(6): 575-88, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23408468